Menu
Log in
  • Home
  • News
  • AstraZeneca likely to run 'additional' COVID-19 vaccine trial as tricky questions emerge


AstraZeneca likely to run 'additional' COVID-19 vaccine trial as tricky questions emerge

27 Nov 2020 12:02 PM | Anonymous

AstraZeneca is facing tricky questions about its success rate that some experts say could hinder its chances of getting speedy US and EU regulatory approval. SBS reports


Powered by Wild Apricot Membership Software